For instance, it has been shown to increase in Gitelman syndrome or through NCC inhibition by thiazides (314, 319) and to decrease in PHAII as well as in hypertensive Mongolian families who would be presumably affected by gain-of-function polymorphisms in NCC (320–322). Here, SLC12A3 is linked to Gitelman syndrome.